top of page
Search

Regenerative Otology: Why PhonoGraft Could Change the Standard of Eardrum Repair

Split-screen image showing a medical microscope on the left in gray-blue and a close-up of an inner ear with a glowing implant on the right.

Abstract

The repair of the tympanic membrane (TM) represents a foundational challenge in otology, bridging the disciplines of microsurgery, acoustics, and tissue engineering. For decades, the surgical standard of care—tympanoplasty utilizing autologous tissue grafts—has remained largely static, burdened by inherent limitations regarding donor site morbidity, acoustic impedance mismatching, and the necessity for invasive operative environments. The PhonoGraft, a novel biomedical device emerging from the Wyss Institute for Biologically Inspired Engineering at Harvard University, signals a transformative shift toward regenerative otology. By leveraging advanced 3D bioplotting technologies and a proprietary biodegradable polyurethane elastomer, the PhonoGraft mimics the anisotropic, radial-circular architecture of the native eardrum. This report provides an exhaustive examination of the PhonoGraft platform, tracing its trajectory from the clinical impetus of the 2013 Boston Marathon bombings to its commercial maturation under Desktop Health. We explore the device's intricate material science, its validated efficacy in chinchilla models, the regulatory complexities of its FDA 510(k) pathway, and its potential to democratize hearing restoration through office-based, minimally invasive procedures.

1. Introduction: The Global Burden of Tympanic Perforations

The sense of hearing is a primary modality through which humans interact with their environment, yet the mechanical interface that facilitates this sense—the middle ear—is remarkably fragile. The tympanic membrane (TM), or eardrum, serves as the critical barrier and acoustic transducer between the external auditory canal and the ossicular chain. Its integrity is paramount not only for sound conduction but also for the protection of the middle ear mucosa from pathogens and environmental debris.

1.1 Epidemiology and Etiology

Tympanic membrane perforations (TMPs) are a pervasive global health issue, affecting millions of individuals annually.1 The etiology of these defects is diverse, ranging from the sequelae of acute and chronic otitis media to traumatic insults.

  • Infectious Etiology: Chronic Suppurative Otitis Media (CSOM) remains a leading cause of TMPs, particularly in developing nations where access to early antibiotic therapy is limited. The resulting chronic perforations often lead to persistent drainage (otorrhea) and progressive conductive hearing loss.

  • Traumatic Etiology: Physical trauma, such as cotton swab insertion or barotrauma from diving and aviation, accounts for a significant proportion of acute perforations.

  • Blast Injury: A distinct and severe category of trauma involves blast overpressure waves. The rapid compression and subsequent rarefaction of air caused by high-explosive detonations can shred the tympanic membrane. This etiology gained tragic local prominence in Boston following the Marathon bombings on April 15, 2013. The pressure waves from the improvised explosive devices (IEDs) resulted in a surge of complex, non-healing eardrum perforations among survivors, overwhelming local otologic resources and highlighting the deficiencies in rapid, effective repair techniques.1

1.2 Limitations of the Surgical Standard of Care

The prevailing surgical intervention for chronic TMPs is tympanoplasty, a procedure first systematized in the 1950s by Wullstein and Zoellner.4 While techniques have evolved, the fundamental principle remains the distinct "patching" of the hole using autologous tissue.

The most common graft materials are temporalis fascia (connective tissue from the muscle covering the skull) and tragal cartilage (from the outer ear).5 While these materials are biocompatible, they possess significant drawbacks:

  1. Acoustic Impedance Mismatch: Native eardrum tissue is highly organized to conduct sound. Fascia is irregular, and cartilage is stiff and massive. Using these materials often results in a "thicker" eardrum that dampens high-frequency vibrations, leading to residual air-bone gaps (conductive hearing loss).5

  2. Donor Site Morbidity: Harvesting these tissues requires additional incisions, extending operative time and increasing postoperative pain and scarring.9

  3. Surgical Invasiveness: Traditional tympanoplasty is a major microsurgical undertaking, typically requiring general anesthesia and 60 to 150 minutes of operative time. This restricts the procedure to fully equipped hospital settings, limiting access for patients in rural or low-resource areas.3

  4. Failure Rates: Despite best efforts, reperforation or failure of the graft to integrate occurs in approximately 10-20% of cases, necessitating revision surgeries.6

It was against this backdrop of clinical necessity that Dr. Aaron Remenschneider and Dr. Elliott Kozin, otolaryngologists at Massachusetts Eye and Ear (MEE), sought a better solution. Their collaboration with Professor Jennifer Lewis’s lab at the Wyss Institute led to the conceptualization of the PhonoGraft—a device designed not merely to close the hole, but to regenerate the functional architecture of the ear.10

2. The Bio-Acoustic Imperative: Anatomy and Physics of the Eardrum

To appreciate the engineering sophistication of the PhonoGraft, one must first dissect the biological complexity it aims to replicate. The tympanic membrane is not a passive skin; it is a sophisticated acoustic receiver tuned by evolution to maximize sensitivity across the frequency spectrum of human speech and environmental sound.

2.1 Micro-Architecture of the Pars Tensa

The eardrum consists of two parts: the smaller, lax pars flaccida superiorly, and the larger, taut pars tensa inferiorly. The pars tensa is the primary vibrating surface and the target for most reconstructive efforts. Structurally, it is a trilaminar membrane:

  1. Lateral Epidermal Layer: Continuous with the skin of the external auditory canal.

  2. Medial Mucosal Layer: Continuous with the lining of the middle ear cleft.

  3. Intermediate Fibrous Layer (Lamina Propria): This is the functional core of the eardrum and the hardest to replicate.

The lamina propria contains a highly specific arrangement of collagen fibers. Radiating outward from the center (the umbo, where the malleus attaches) are radial fibers. Interwoven with these are concentric circular fibers.11

This "wheels and spokes" architecture creates an anisotropic material—its mechanical properties differ depending on the direction of the force. The radial fibers transmit the acoustic energy to the ossicles, while the circular fibers provide the tension and structural integrity required to resist static pressure changes.13

2.2 Acoustic Impedance and Frequency Response

The function of the middle ear is impedance matching. Sound travels efficiently through air (low impedance) but reflects off water (high impedance). Since the inner ear (cochlea) is fluid-filled, direct sound transmission would result in a loss of approximately 99.9% of acoustic energy (a roughly 30 dB loss).

The tympanic membrane acts as a transformer. Its large surface area relative to the small footplate of the stapes amplifies the pressure. However, this amplification relies on the membrane’s ability to vibrate in complex modes.

  • Low Frequencies (< 1 kHz): The eardrum moves largely as a rigid piston.

  • High Frequencies (> 3 kHz): The eardrum motion breaks up into multiple vibrational zones.

Autologous grafts like cartilage have a high mass and stiffness. While excellent for durability, they can act as a low-pass filter, effectively transmitting low tones but damping the high-frequency vibrations essential for speech intelligibility (consonants) and music appreciation.8 The primary design goal of the PhonoGraft was to match the Young's modulus (elasticity) and mass of the native TM to restore this full-spectrum fidelity.8 Snippets indicate the native TM has a Young's modulus in the range of 20-30 MPa, a target the PhonoGraft material approximates closely to avoid the stiffness-induced hearing loss seen with cartilage.15

3. Materials Science: The Polymer Innovation

The development of the PhonoGraft necessitated a departure from standard medical materials. Initial experiments by the Harvard team utilized silicone, a material widely used in medical implants due to its inertness. However, silicone proved to be a failure in the context of tympanic regeneration. Because it is non-biodegradable and chemically inert, cells would not migrate into it; they would grow over it, resulting in a bilayered structure that never truly integrated or healed. Furthermore, the acoustic properties of a solid silicone sheet did not match the complex frequency response of the fibrous native drum.11

3.1 The "AlignInk" System

Recognizing the need for a material that was both structurally tunable and biologically active, Nicole Black and the Lewis Lab developed a novel synthetic polymer-based ink system, referred to in commercial contexts as "AlignInk".12

Based on the research snippets, the core material is a biodegradable polyurethane elastomer (specifically a poly(ester urethane) urea, or P-PEUU).1

  • Chemistry: Polyurethanes are block copolymers consisting of "hard" segments (providing structural integrity) and "soft" segments (providing elasticity). By adjusting the stoichiometry of these segments, the researchers could tune the mechanical properties—specifically the tensile strength and elasticity—to match the native eardrum exactly.19

  • Biodegradability: Unlike permanent silicone, this polyurethane formulation includes hydrolytically labile bonds (likely ester linkages or incorporated PEG chains). This allows the material to break down over a programmed timeframe (typically 3-6 months) when exposed to physiological fluids. This degradation rate is critical: the scaffold must maintain its structural integrity long enough to support the migrating cells but eventually dissolve completely to leave behind only natural tissue.1

3.2 3D Bioplotting and Biomimicry

The fabrication of the PhonoGraft utilizes Direct Ink Writing (DIW), also known as 3D bioplotting. This is an extrusion-based additive manufacturing technique where the viscous polymer ink is dispensed through a microscopic nozzle.21

Unlike fused deposition modeling (FDM), which melts hard plastics, DIW works with rheologically complex fluids. The ink must be shear-thinning (flowing easily through the nozzle) but have a high yield stress (holding its shape immediately upon deposition).21

The printer deposits the filament in the precise radial and circular pattern identified in the native eardrum.11

  • Macroscopic Control: The printer builds the graft with a conical geometry to mimic the natural shape of the TM.

  • Microscopic Control: The filaments are spaced to create a porous lattice. The diameter of the filaments (controlled by print speed and pressure) and the spacing between them (pore size) are optimized to allow cell migration.The resulting scaffold is anisotropic, meaning it has different mechanical properties in the radial versus circular directions, mirroring the "wheels and spokes" mechanics of the natural tissue.10

Material Property

Autologous Fascia

PhonoGraft (Polyurethane)

Clinical Implication

Structure

Random, isotropic fibers

Ordered, anisotropic (Radial/Circular)

PhonoGraft mimics native vibration modes for better hearing.

Degradation

Does not degrade (incorporates)

Fully biodegradable (approx. 3 months)

PhonoGraft leaves no foreign body behind; reduced long-term infection risk.

Porosity

Low / Variable

High / Tunable

PhonoGraft facilitates rapid cell migration and vascularization.

Stiffness

Low (flaccid)

Tunable (~20 MPa)

PhonoGraft resists retraction while maintaining vibration.

4. Preclinical Validation: The Chinchilla Model

The leap from the laboratory bench to human application required rigorous in vivo validation. The selection of an appropriate animal model was crucial for the translation of the PhonoGraft technology.

4.1 The Chinchilla Lanigera Model

While rodents like mice and rats are common in biomedical research, their auditory anatomy is vastly different from humans. Their ear canals are tiny, and their hearing range extends far into the ultrasonic. The research team selected the chinchilla (Chinchilla lanigera) as the primary model for PhonoGraft validation.11

  • Anatomical Similarity: The chinchilla possesses a large auditory bulla and a tympanic membrane that is readily accessible and similar in size to the human eardrum.24

  • Audiological Overlap: The hearing range of the chinchilla overlaps significantly with the human speech frequencies (250 Hz – 4 kHz), making it an excellent predictor of functional hearing outcomes in humans.24

4.2 Study Design and Results

The team performed controlled surgeries on chinchillas, creating chronic perforations and repairing them with the PhonoGraft. The results, published in journals such as Hearing Research (e.g., Kozin et al., 2016), were transformative.26

1. Morphological Regeneration:

Endoscopic monitoring over a 3-month period revealed a distinct healing progression. Initially, the white lattice of the graft was visible. Over weeks, the graft became vascularized and covered by epithelium. By the three-month endpoint, the graft material had degraded, and the eardrum appeared translucent and healthy. Dr. Remenschneider described seeing "merely the ghost of our graft... replaced with new tissue".11 Histological analysis confirmed that the regenerated tissue possessed all three layers of the native eardrum, including the critical organized collagen layer, which guided the structural integrity.11

2. Acoustic Recovery:

Functional testing using Laser Doppler Vibrometry (LDV) and Auditory Brainstem Response (ABR) measured the movement of the eardrum and the neural response to sound.

  • Vibrometry: The regenerated eardrums exhibited vibration velocities identical to native controls across the frequency spectrum.

  • Hearing Thresholds: The study demonstrated a full closure of the Air-Bone Gap (ABG). In control groups using other materials, residual conductive hearing loss (gap > 10 dB) is common, particularly at high frequencies. The PhonoGraft chinchillas showed a complete restoration of sound conduction.11

This "Eureka moment" confirmed that the biomimetic architecture did not just look like an eardrum; it acted like one, successfully teaching the body to rebuild a complex acoustic sensor.11

5. Commercialization: From Beacon Bio to Desktop Health

The transition of the PhonoGraft from an academic project to a commercial product highlights the robust translational ecosystem at Harvard.

5.1 The Formation of Beacon Bio

Following the completion of her PhD in 2020, Nicole Black, along with Professors Lewis, Remenschneider, and Kozin, founded Beacon Bio.25 The startup secured an exclusive license from Harvard's Office of Technology Development (OTD) to commercialize the PhonoGraft IP.

Beacon Bio was quickly recognized in the innovation community, winning the $25,000 Health & Life Sciences prize at the Harvard President’s Innovation Challenge and the Collegiate Inventors Competition.5 The primary objective of the startup was to refine the manufacturing process for Good Manufacturing Practice (GMP) compliance and to prepare the regulatory dossier for the FDA.17

5.2 Acquisition by Desktop Health

In July 2021, less than a year after its inception, Beacon Bio was acquired by Desktop Health, a healthcare-focused subsidiary of the additive manufacturing giant Desktop Metal (NYSE: DM).29

This acquisition was synergistic. Desktop Metal manufactures the 3D-Bioplotter (via its EnvisionTEC acquisition), the very machine used to print the PhonoGraft.22 This vertical integration meant that the device design and the manufacturing hardware were under the same roof, simplifying the path to industrial scaling.

Nicole Black assumed the role of Vice President of Biomaterials and Innovation at Desktop Health, ensuring that the original scientific vision continued to guide the product's development.5

5.3 The PhonoGraft Manufacturing Platform

The manufacturing of PhonoGraft at Desktop Health leverages the high-precision capabilities of the 3D-Bioplotter.

  • Traceability: The manufacturing system includes overhead cameras for medical device traceability, ensuring that every printed graft is verified against the digital file—a requirement for FDA Quality Management Systems (QMS).22

  • Scalability: Unlike hand-carved cartilage grafts, the PhonoGraft can be serially manufactured. A single print run can produce multiple grafts, ensuring uniformity and availability.22

6. Regulatory Pathway and FDA Status

Navigating the FDA landscape is a critical hurdle for any novel biomaterial. The PhonoGraft is classified as a medical device (likely Class II) intended for tympanic membrane reconstruction.

6.1 The 510(k) Strategy

The team is pursuing the 510(k) regulatory pathway.10 This pathway requires demonstrating that the new device is "substantially equivalent" to a legally marketed predicate device (e.g., existing patch materials like paper or hyaluronic acid derivatives).

However, the "regenerative" claims of PhonoGraft add complexity. While traditional patches are passive mechanical barriers, PhonoGraft claims to induce tissue remodeling.

6.2 Clinical Trial Requirements

In pre-submission meetings, the FDA indicated that due to the novel nature of the device and its transcanal delivery method, a human confirmatory study would be required.12 This study aims to validate:

  1. Safety: Absence of adverse immune reactions or infection.

  2. Placement Efficacy: confirming that the device can be successfully placed in both the Operating Room (OR) and office settings.

  3. Healing Outcomes: verifying the closure of perforations in humans.

As of late 2024 and early 2025, Desktop Health is actively working toward this clearance. Public statements have targeted a potential clearance timeline around late 2025, though regulatory timelines are inherently fluid.22 The recent acquisition of Desktop Metal by Nano Dimension (mentioned in snippets) introduces a new corporate context, though the commitment to the healthcare division appears stable.32

7. The Clinical Paradigm Shift: Office-Based Otology

The most disruptive potential of the PhonoGraft lies not just in its material properties, but in how it changes the delivery of care.

7.1 From OR to Office

Current tympanoplasty is a major logistical event. It involves:

  • General Anesthesia: Necessary for patient immobility during microscopic work and graft harvesting.9

  • Post-Auricular Incision: A cut behind the ear to access the drum and harvest fascia.6

  • Time and Cost: 2-3 hours of facility time, resulting in costs exceeding $10,000-$30,000 in the US healthcare system.3

The PhonoGraft is designed for Endoscopic Transcanal Tympanoplasty.

  • No Incisions: The graft is inserted through the natural ear canal (transcanal).

  • No Harvesting: The synthetic graft eliminates the need to cut muscle or cartilage from the patient.33

  • Local Anesthesia: Because there is no major incision, the procedure can be performed with the patient awake, using only numbing drops or local injections.34

  • Speed: The procedure time is estimated to drop to 20-30 minutes.9

7.2 Democratization of Access

This shift has profound implications for global health. In developing nations where access to sterile operating theaters and anesthesiologists is limited, the burden of untreated eardrum perforations is immense. A shelf-stable, synthetic graft that can be placed by an ENT in a simple clinic room could enable mass treatment campaigns, preventing lifelong hearing disability in millions of children and adults.3

Similarly, in military medicine, the prevalence of blast injuries among service members creates a need for rapid, forward-deployed repair options. The PhonoGraft aligns perfectly with the Department of Defense's interest in regenerative medicine for battlefield trauma.1

8. Broader Horizons: Platform Technology

While the eardrum is the initial target, the underlying technology—biodegradable, anisotropically printed elastomers—is a platform with wider applications.

8.1 Vascular and Cardiac Repair

The "AlignInk" system can be used to print scaffolds for other soft tissues that require flexibility and strength.

  • Vascular Grafts: Blood vessels have a muscular wall with aligned fibers. PhonoGraft-style tubes could replace damaged vessels, promoting endothelialization without the thrombosis risks of permanent synthetic grafts.19

  • Cardiac Patches: Following a heart attack, the heart muscle scars and loses contractility. A conductive, elastic patch could bridge the damaged area, guiding the alignment of cardiomyocytes to restore pumping function.36

8.2 Neural Regeneration

Nerve guidance conduits are used to bridge gaps in severed nerves. The ability to print longitudinal fibers could provide the "tracks" for axons to regenerate across a defect, potentially improving outcomes in peripheral nerve injuries.29

9. Conclusion

The PhonoGraft represents a convergence of three revolutions: the materials revolution (biodegradable elastomers), the manufacturing revolution (3D bioprinting), and the surgical revolution (minimally invasive regeneration).

By looking to nature for design principles—specifically the radial and circular architecture of the tympanic membrane—the team at Harvard and Desktop Health has created a device that promises to solve a decades-old clinical problem.

If the upcoming clinical trials validate the successes seen in the chinchilla models, PhonoGraft will not only improve hearing outcomes for patients but will fundamentally restructure the economics and accessibility of otologic care. It marks a step away from the era of "patching" the body with spare parts and toward an era of instructing the body to heal itself.

Technical Addendum: Data and Comparisons

Table 1: Comparative Analysis of Tympanic Membrane Graft Materials

Feature

Temporalis Fascia (Standard of Care)

Tragal Cartilage

PhonoGraft (Synthetic)

Origin

Autologous (Patient's Muscle)

Autologous (Patient's Ear Cartilage)

Synthetic (Biodegradable P-PEUU)

Harvest Requirement

Yes (Incision required)

Yes (Incision required)

No (Off-the-shelf)

Structure

Irregular, Isotropic Fibers

Solid, Stiff Plate

Biomimetic Radial/Circular Fibers

Acoustic Impedance

Variable; often good

High Impedance (Mass dominated)

Matched to Native TM (~20 MPa)

High Freq. Transmission

Good

Poor (Damping effect)

Excellent (Native-like)

Surgical Time

60-120 mins

60-120 mins

~20-30 mins

Anesthesia

General

General

Local / Office-based

Healing Mechanism

Scaffolding (Passive)

Scaffolding (Passive)

Guided Tissue Regeneration (Active)

Table 2: Key Milestones in PhonoGraft Development


Year

Milestone

Context

2013

Boston Marathon Bombings

Surge in blast-induced TMPs highlights clinical need.2

2014-2016

Early R&D

Exploration of silicone (failed); Development of P-PEUU ink.17

2016

Hearing Research Publication

Kozin et al. publish proof-of-concept and acoustic tuning data.26

2018-2020

Chinchilla Trials

In vivo validation shows full healing and acoustic recovery.11

2020

Beacon Bio Founded

Nicole Black spins out technology from Wyss Institute.25

2021

Acquisition by Desktop Health

Technology enters industrial commercialization phase.29

2022-2024

FDA Pre-Submission

Definition of 510(k) pathway and human study protocols.12

2025 (Proj.)

FDA Clearance Target

Anticipated market entry for clinical use.22


Note: This report synthesizes information from publicly available research snippets provided. The device described is currently an investigational device and subject to regulatory review.


Works cited

  1. Nicole Black Harvard University - Lemelson-MIT Program, accessed January 2, 2026, https://lemelson.mit.edu/sites/default/files/2021-04/Invention_Fact_Sheet_For_Nicole_Black.pdf

  2. Healing Ruptured Eardrums With A New 3-D Printed Graft - William A. Haseltine PhD, accessed January 2, 2026, https://www.williamhaseltine.com/healing-ruptured-eardrums-with-a-new-3-d-printed-graft/

  3. Innovators Use 3D-Printing to Treat Eardrum Injuries | IP Progress, accessed January 2, 2026, https://ipprogress.world/articles/innovators-use-3d-printing-treat-eardrum-injuries

  4. The role of different types of grafts in tympanoplasty - PMC - NIH, accessed January 2, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC9444664/

  5. Interview with Dr. Nicole Black: 3D-Printed Biomimetic Eardrum Grafts - 3DHeals, accessed January 2, 2026, https://3dheals.com/interview-with-dr-nicole-black-3d-printed-regenerative-tissue-grafts/

  6. Advantages of hyaluronic acid fat graft myringoplasty over fat graft myringoplasty., accessed January 2, 2026, https://www.tampabayhearing.com/advantages-hyaluronic-acid-fat-graft-myringoplasty-fat-graft-myringoplasty/

  7. Tympanoplasty | Johns Hopkins Medicine, accessed January 2, 2026, https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/tympanoplasty

  8. Fascia versus cartilage graft in type I tympanoplasty: audiological outcome - PubMed, accessed January 2, 2026, https://pubmed.ncbi.nlm.nih.gov/23172493/

  9. Nicole Black - Lemelson-MIT Program, accessed January 2, 2026, https://lemelson.mit.edu/award-winners/nicole-black

  10. Harvard's eardrum-restoring PhonoGraft enters commercial development, accessed January 2, 2026, https://otd.harvard.edu/news/harvards-eardrum-restoring-phonograft-enters-commercial-development/

  11. 3D-Printed Eardrum Graft in Commercial Development - Plastics Today, accessed January 2, 2026, https://www.plasticstoday.com/medical/3d-printed-eardrum-graft-in-commercial-development-44246

  12. Capitalizing on 3D-Printing for Medical Device Manufacturing, accessed January 2, 2026, https://www.mddionline.com/3d-printing/capitalizing-on-3d-printing-for-medical-device-manufacturing

  13. September 2023 - 3DHeals, accessed January 2, 2026, https://3dheals.com/2023/09/

  14. Effect of the weight of cartilage and fascia grafts on the audiological outcome of myringoplasty - SciTechnol, accessed January 2, 2026, https://www.scitechnol.com/proceedings/effect-of-the-weight-of-cartilage-and-fascia-grafts-on-the-audiological-outcome-of-myringoplasty-3275.html

  15. Models of Cochlea Used in Cochlear Implant Research: A Review - PMC - PubMed Central, accessed January 2, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10264527/

  16. Recent Developments in FullField Thickness Measurements of the Human Eardrum, accessed January 2, 2026, https://www.researchgate.net/publication/316458346_Recent_Developments_in_FullField_Thickness_Measurements_of_the_Human_Eardrum

  17. A sound solution - Harvard School of Engineering and Applied Sciences, accessed January 2, 2026, https://seas.harvard.edu/news/2021/05/sound-solution

  18. The stepwise continuum to bioprinted medical device innovation, accessed January 2, 2026, https://businessofbiofabrication.com/2023/10/13/the-stepwise-continuum-to-bioprinted-medical-device-innovation/

  19. 3D Printed Biodegradable Polymeric Vascular Grafts - PMC - NIH, accessed January 2, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC4749136/

  20. Synthetic Polymers for Organ 3D Printing - PMC - PubMed Central, accessed January 2, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC7466039/

  21. 85 Results for 'Jennifer A. Lewis' - Wyss Institute, accessed January 2, 2026, https://wyss.harvard.edu/keywords/Jennifer+A.+Lewis/

  22. 3D-BIOPLOTTER - Sim Technologies, accessed January 2, 2026, https://simtek.in/wp-content/uploads/2024/06/DH-3D-Bioplotter-Brochure-07212023_compressed-1-1.pdf

  23. Effects of semicircular canal electrode implantation on hearing in chinchillas, accessed January 2, 2026, https://pure.johnshopkins.edu/en/publications/effects-of-semicircular-canal-electrode-implantation-on-hearing-i-5

  24. Finite Element Modeling of Residual Hearing after Cochlear Implant Surgery in Chinchillas, accessed January 2, 2026, https://www.mdpi.com/2306-5354/10/5/539

  25. Harvard's eardrum-restoring PhonoGraft enters commercial development, accessed January 2, 2026, https://seas.harvard.edu/news/2021/08/harvards-eardrum-restoring-phonograft-enters-commercial-development

  26. Design, Fabrication, and In Vitro Testing of Novel Three-Dimensionally Printed Tympanic Membrane Grafts | Request PDF - ResearchGate, accessed January 2, 2026, https://www.researchgate.net/publication/298723969_Design_Fabrication_and_In_Vitro_Testing_of_Novel_Three-Dimensionally_Printed_Tympanic_Membrane_Grafts

  27. New Bioengineering Techniques for Tympanic Membrane Repair Using 3D Printing - ResearchGate, accessed January 2, 2026, https://www.researchgate.net/publication/382902446_3-D_Printed_Scaffolds_the_Building_Blocks_to_a_New_Way_to_Repair_the_Eardrum/fulltext/66b23e818f7e1236bc40a452/3-D-Printed-Scaffolds-the-Building-Blocks-to-a-New-Way-to-Repair-the-Eardrum.pdf

  28. Creator of PhonoGraft makes Forbes 30 under 30 list : r/DesktopMetal - Reddit, accessed January 2, 2026, https://www.reddit.com/r/DesktopMetal/comments/rw79yf/creator_of_phonograft_makes_forbes_30_under_30/

  29. Desktop Health acquires eardrum-regenerating 3D bioprinting technology - lino.gr, accessed January 2, 2026, https://www.lino.gr/desktop-health-acquires-eardrum-regenerating-3d-bioprinting-technology/

  30. Alumni startup acquired by Desktop Health, accessed January 2, 2026, https://seas.harvard.edu/news/2021/07/alumni-startup-acquired-desktop-health

  31. Desktop Health - Greentown Labs, accessed January 2, 2026, https://greentownlabs.com/members/desktop-health/

  32. Desktop Health Adds PhonoGraft Biofabrication Platform to Growing Technology Portfolio, accessed January 2, 2026, https://www.businesswire.com/news/home/20210707005418/en/Desktop-Health-Adds-PhonoGraft-Biofabrication-Platform-to-Growing-Technology-Portfolio

  33. PhonoGraft: Programming the eardrum to repair itself - YouTube, accessed January 2, 2026, https://www.youtube.com/watch?v=nKjfoXLLeAM

  34. This 3D-printed graft may improve ruptured eardrum surgery - Freethink Media, accessed January 2, 2026, https://www.freethink.com/health/ruptured-eardrum-surgery

  35. The Burden of Fingertip Trauma on the US Military | Request PDF - ResearchGate, accessed January 2, 2026, https://www.researchgate.net/publication/347824201_The_Burden_of_Fingertip_Trauma_on_the_US_Military

  36. Desktop Health Buys Tech for 3D Printing Eardrum Grafts - 3DPrint.com | Additive Manufacturing Business, accessed January 2, 2026, https://3dprint.com/283078/phonograft-platform-for-3d-printing-biomimetic-eardrum-grafts-acquired-by-desktop-health/

bottom of page